Exhale

The official blog of the Lung Institute.

Pulmonary Fibrosis Stages, Prognosis and Life Expectancy

Pulmonary Fibrosis Stages, Prognosis and Life Expectancy

Everything you need to know about pulmonary fibrosis stages, prognosis and life expectancy and what to do next.

For those who are living with pulmonary fibrosis (PF), the shock of the initial diagnosis is often devastating. As a degenerative lung disease, the development of pulmonary fibrosis can often mean significant changes in habits and behaviors moving forward. As pulmonary fibrosis is broken down into stages, an assessment is given of a patient’s current health (prognosis), and a prediction of their anticipated life expectancy is determined, the next step is often addressing issues of lifestyle and suggestions for pulmonary fibrosis treatment options. Although this can be a lot of information to absorb at once, it’s vitally important to take control of the management of one’s health and assuring a better quality of life after a PF diagnosis.

With your health in mind, the Lung Institute is here to break down Pulmonary Fibrosis Stages, Prognosis, and Life Expectancy.

Pulmonary Fibrosis Stages

Unlike cases of chronic obstructive pulmonary disease (COPD), where staging of the disease utilizes measurement techniques such as the GOLD System and BODE Index, pulmonary fibrosis staging is a bit harder to define. Traditionally, pulmonary fibrosis has been put into stages of mild, early, severe and advanced and these stages are based primarily on pulmonary function tests. Although these designations are helpful for doctors in monitoring disease progression and advising patients, these stages don’t account for particular variables. As it stands, doctors have been developing a new staging system called the GAP Index, which utilizes four predictors: age, recent respiratory hospitalization, baseline FVC and 24-week change in FVC. After combining these scores, a stage diagnosis is assessed, allowing patients with pulmonary fibrosis to have a more accurate measure of their respiratory health.

Pulmonary Fibrosis Prognosis

Pulmonary Fibrosis Stages, Prognosis and Life Expectancy

A prognosis is nothing more than an assessment of your disease’s progression. In essence, it’s a more detailed depiction of disease stage, and associated symptoms and life expectancy (more on that later). Symptoms and indicators of disease progression include:

  • Disturbed sleep patterns
  • Need for intensive home support
  • Frequent flare-ups and hospitalizations
  • Increased severity in shortness of breath
  • Difficulty maintaining a healthy body weight
  • Chest pain
  • Depression
  • Poor appetite
  • Increased anxiety
  • Bothersome cough
  • Becoming housebound
  • Reduced lung function

Life Expectancy with Pulmonary Fibrosis

Determining the stage of pulmonary fibrosis is a subjective call made by your doctor, so predicting life expectancy with pulmonary fibrosis includes a margin of error. The rate of PF disease progression is inherent to the genetics and lifestyle habits of the individual’s themselves. For some, the disease progression may appear rapidly, leading to an increased pronouncement of symptoms. For others, the disease may progress more slowly, allowing a greater quality of life to continue for years. These differences in disease progression can have a significant effect on one’s lifestyle habits and behaviors. For example, to better improve one’s life expectancy and quality of life, it is imperative to quit smoking, follow a healthy diet, and exercise to as great a capacity as one is able.

Moving Forward with the Pulmonary Fibrosis Stages, Prognosis and Life Expectancy

Pulmonary Fibrosis Stages, Prognosis and Life Expectancy

A pulmonary fibrosis diagnosis, and the lack of information it can present, can create many difficulties in the lives of those who have been diagnosed. It’s important to understand the pulmonary fibrosis stages, prognosis and life expectancy, so you can stay proactive in your healthcare. Though PF can seem impossible to overcome, changing one’s diet and consistently exercising are among the best lifestyle changes aside from quitting smoking. When lifestyle changes fail to improve your quality of life in the way that you may expect, it may be time to consider cellular therapy. Rather than simply addressing the symptoms of lung disease, cellular therapy directly affects disease progression and can improve quality of life and pulmonary function.

If you or a loved one suffers from a chronic disease like PF, COPD, ILD or other symptoms of lung disease, the Lung Institute may be able to help with a variety of adult cellular therapy options. Contact us today at (800) 729-3065 to see if you qualify for cellular therapy, and find out what cellular therapy could mean for you.

Interested in our article on Pulmonary Fibrosis Stages, Prognosis and Life Expectancy? Share your thoughts and comments below.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.